|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/175 | |
| A61K 31/17 | |||
| A61K 31/164 | |||
| A61K 31/18 | |||
| A61K 31/10 | |||
| A61K 31/045 | |||
| A61K 31/05 | |||
| A61K 31/04 | |||
| A61K 31/03 | |||
| A61K 31/02 | |||
| A61P 9/10 | |||
| A61K 31/16 | |||
| A61K 45/06 |
| (11) | Number of the document | 2111224 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08727620.0 |
| Date of filing the European patent application | 2008-01-11 | |
| (97) | Date of publication of the European application | 2009-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/050922 |
| Date | 2008-01-11 |
| (87) | Number | WO 2008/089103 |
| Date | 2008-07-24 |
| (30) | Number | Date | Country code |
| 880119 P | 2007-01-12 | US | |
| 923378 P | 2007-04-13 | US | |
| 952396 P | 2007-07-27 | US | |
| 12613 | 2007-12-10 | US |
| (72) |
SIMARD, J., Marc, US
|
| (73) |
University of Maryland, Baltimore,
Office of Research & Development 620 W. Lexington Street, 4th Floor, Baltimore, MD 21201-1691,
US
The United States of America, as represented by the Department of Veterans Affairs, Office of General Counsel - PSG IV (024) 810 Vermont Ave. N. W., Washington, D.C. 20420, US |
| (54) | TARGETING NCCA-ATP CHANNEL FOR ORGAN PROTECTION FOLLOWING ISCHEMIC EPISODE |
| TARGETING NCCA-ATP CHANNEL FOR ORGAN PROTECTION FOLLOWING ISCHEMIC EPISODE |